How should SOD, MDA, glutathione and antioxidant pathways be combined?

When conducting an oxidative stress experiment, the most common outcome is likely as follows:

Model group: ROS levels increase, MDA levels rise, SOD decreases, and glutathione decreases.

The treatment group: All of the above results are reversed.

It seems complete, but as long as one indicator does not change as expected, many people will not know how to interpret it.

A more common problem is: Only measuring DCFH-DA fluorescence, seeing an increase in ROS, and directly concluding that "the cells are experiencing oxidative stress".

This actually combines "oxidative signals", "antioxidant defense", and "oxidative damage" into one thing.

An increase in ROS does not automatically mean oxidative stress.

More convincing evidence should simultaneously answer three questions:

Has the oxidative-related signal increased?

Has the antioxidant system become imbalanced?

Have lipids, proteins, or DNA already suffered oxidative damage?

SOD, MDA and glutathione do not address same issue respectively.

1. A decrease in SOD indicates impaired antioxidant capacity, but an increase in SOD can also occur during oxidative stress.

SOD converts superoxide anions into hydrogen peroxide, and then CAT, GPx, etc. are needed to further process the hydrogen peroxide.

SOD does not act independently.

During severe or persistent damage, the activity of SOD may decrease;

However, in the early stage of stress or when the stimulus is mild, cells may also compensate by increasing the expression or activity of SOD.

At this point, "an increase in SOD" does not mean the absence of oxidative stress; it may indicate that the defense system is being mobilized.

Common mistake: When WB detects an increase in SOD2 protein, it is written as "enhanced SOD activity".

Protein expression level is not the same as enzyme activity;

If the conclusion involves antioxidant capacity, it is best to directly conduct SOD activity detection.

2. An increase in MDA indicates lipid peroxidation, but TBARS results should not be over-interpreted.

MDA is one of the reactive aldehydes formed during the oxidation of polyunsaturated fatty acids, and is thus often used to assess lipid peroxidation.

However, many kits use TBA for color development, and what is actually measured is "thiobarbituric acid reaction product", which is not specific to MDA alone;

Sample processing, storage time, acidic high-temperature reactions, and other substances that can react with TBA may all affect the results.

MDA can be used as supporting evidence, but should not bear the entire conclusion alone.

If conditions permit, complementary indicators such as 4-HNE protein adducts, F2-isoprostanes, or lipid ROS can be added.

3. A decrease in glutathione is quite common, but an increase in glutathione does not necessarily indicate that oxidative stress has been improved.

Glutathione is an important non-enzymatic antioxidant molecule within cells.

It is consumed and forms oxidized glutathione when clearing peroxides, maintaining protein sulfhydryl groups, and supporting the GPx reaction.

A decrease in glutathione, an increase in oxidized glutathione, and a decrease in GSH/oxidized glutathione are usually more indicative of an enhanced oxidative environment.

However, cells may also increase glutathione synthesis through pathways such as Nrf2—GCLC/GCLM, resulting in a short-term increase in total glutathione or GSH.

This could be a successful compensation or merely a defense response to continuous oxidative stimulation.

Measuring the total amount of glutathione alone is difficult to distinguish between these two situations.

Pre-treatment is particularly crucial:

After sampling, glutathione can continue to oxidize in vitro, causing a false increase in oxidized glutathione.

Studies have shown that if the sulfhydryl groups are not stabilized in time, the results of blood oxidized glutathione are easily affected by significant in vitro artifacts.

How should it be combined?

Choose based on "to what extent you want to prove".

Combination A: Basic Screening Type - Demonstrates signs of oxidative imbalance

Recommendation: ROS + SOD activity + MDA + Glutathione

Suitable for pre-experiments or projects with limited funds.

Advantage: Covers oxidation, defense, and lipid damage;

Disadvantage: Glutathione redox state and damage specificity are still relatively weak.

Combination B: More Complete Phenotype Type - Forms a more reliable chain of evidence for oxidative stress

Recommendation: ROS + SOD activity + CAT or GPx activity + GSH/oxidized glutathione + MDA or 4-HNE

Compared to the basic combination, it can more clearly determine the multi-level antioxidant enzyme defense line and glutathione redox state.

If the project emphasizes DNA damage, 8-OHdG can be added;

If emphasizing protein damage, protein carbonyls or 3-nitrotyrosine can be added.

Combination C: Mechanism Type - Demonstrates that a certain antioxidant pathway is involved

Recommendation: Combination B + Nrf2 nuclear translocation + downstream enzymes such as HO-1/NQO1/GCLC + pathway intervention + phenotype rescue

If after knocking down Nrf2, the improvement of the drug on ROS, oxidative damage, and cell function significantly weakens, it is closer to the causal evidence "acting through the Nrf2 pathway".

Don't equate the more indicators with stronger evidence.

Stacking ROS, MDA, SOD, CAT, glutathione, T-AOC, HO-1, NQO1 all at once, if all indicators are only measured once for the same endpoint, it may still be just a set of correlation data.

The strength of evidence comes more from the logical complementarity of indicators, temporal relationship, and reversibility after intervention.

Different samples require further adjustments to combination

Cell experiments

It can detect intracellular ROS, mitochondrial-related oxidative signals, GSH/oxidized glutathione, enzyme activity and lipid peroxidation, while also combining cell viability, apoptosis or mitochondrial function.

The probe results should be reasonably normalized according to the number of living cells or protein quantity, and drug-induced fluorescence should be excluded.

Tissue samples

Tissue homogenates are suitable for biochemical tests such as SOD, CAT, GPx, GSH/oxidized glutathione and MDA;

4-HNE, 8-OHdG or Nrf2 nuclear localization IHC/IF can supplement spatial information.

Homogenate indicators usually need to be normalized according to protein quantity or tissue weight.

Serum or plasma

MDA, T-AOC, SOD in circulation can reflect systemic changes, but they cannot automatically represent oxidative stress in a specific organ.

Hemolysis, separation delay, freeze-thaw and storage conditions may all affect the results;

If the tissue mechanism is to be explained, it is best to pair with the detection of the target tissue.